UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 294

Sortiert nach

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Annals of oncology, 2017-07, Vol.28 (7), p.1605-1611

2017

Volltextzugriff (PDF)

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

Annals of oncology, 2014-04, Vol.25 (4), p.801-807

2014

Volltextzugriff (PDF)

Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines

Annals of oncology, 2011-10, Vol.22 (10), p.2191-2200

2011

Volltextzugriff (PDF)

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

Annals of oncology, 2014-03, Vol.25 (3), p.682-688

2014

Volltextzugriff (PDF)

Variations in PD1, PD-L1, IDO1 and VEGR2 genes and association with outcomes in advanced head and neck squamous cell carcinoma (HNSCC) patients treated with anti-PD1/PD-L1 based immunotherapy

Annals of oncology, 2017-10, Vol.28, p.vii12-vii12

2017

Volltextzugriff (PDF)

SP-052: The role of PD-L1/PD1 pathway in SCCHN

Radiotherapy and oncology, 2015-02, Vol.114, p.29-30

2015

Volltextzugriff (PDF)

Next-generation sequencing reveals high intra-individual molecular concordance between primary head and neck tumors and matched local or distant recurrences

Annals of oncology, 2018-09, Vol.29, p.vi29-vi29

2018

Volltextzugriff (PDF)

PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors

Annals of oncology, 2018-10, Vol.29, p.viii20-viii20

2018

Volltextzugriff (PDF)

Cetuximab in patients with unresectable cutaneous squamous cell carcinoma is safe and effective: A real-life analysis

Annals of oncology, 2018-10, Vol.29, p.viii462-viii462

2018

Volltextzugriff (PDF)

Acceptance of the 2009 A(H1N1) influenza vaccine among hospital workers in two French cancer centers

Vaccine, 2010-10, Vol.28 (43), p.7030-7034

2010

Volltextzugriff (PDF)

The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit

Annals of oncology, 2017-09, Vol.28, p.v375-v376

2017

Volltextzugriff (PDF)

2800 Cabazitaxel in patients with refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Final results of phase II trial UNICANCER ORL03

European journal of cancer (1990), 2015-09, Vol.51, p.S557-S557

2015

Volltextzugriff (PDF)

PO-164: PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic salivary gland carcinoma

Radiotherapy and oncology, 2015-02, Vol.114, p.76-77

2015

Volltextzugriff (PDF)

Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximab

Hematological oncology, 2018-02, Vol.36 (1), p.144-149

2018

Volltextzugriff (PDF)

EP-1084: Elderly patients concomitant radiotherapy + cetuximab in locally advanced head and neck cancer

Radiotherapy and oncology, 2016-04, Vol.119, p.S521-S521

2016

Volltextzugriff (PDF)

PO-075: Induction chemotherapy in locally advanced hypopharynx cancer: treatment outcomes and role of nutritional status

Radiotherapy and oncology, 2015-02, Vol.114, p.39-40

2015

Volltextzugriff (PDF)

RESULTS FROM THE SAFETY RUN‐IN PERIOD OF THE SYMPATICO STUDY EVALUATING IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.333-335

2019

Volltextzugriff (PDF)

Role of radiotherapy in the management of non-Hodgkin lymphomas

Cancer radiothérapie, 2016-05, Vol.20 (3), p.236-247

2016

Volltextzugriff (PDF)

Efficacy of Cetuximab for Unresectable or Advanced Cutaneous Squamous Cell Carcinoma — A Report of Eight Cases

Clinical oncology (Royal College of Radiologists (Great Britain)), 2011-12, Vol.23 (10), p.716-718

2011

Volltextzugriff (PDF)

Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer

European journal of cancer (1990), 2004-09, Vol.40 (14), p.2071-2076

2004

Volltextzugriff (PDF)

Reirradiation of head and neck cancers

Cancer radiothérapie, 2017-10, Vol.21 (6-7), p.521

2017

Volltextzugriff (PDF)

Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older

Journal of clinical oncology, 2021-04, Vol.39 (11), p.1203-1213

2021

Volltextzugriff (PDF)

Head and neck free-flap reconstruction in the elderly

European annals of otorhinolaryngology, head and neck diseases, 2011-04, Vol.128 (2), p.47-51

2011

Volltextzugriff (PDF)

A comparison between distal and proximal port device insertion in head and neck cancer

European journal of surgical oncology, 2008-11, Vol.34 (11), p.1262-1269

2008

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(263)
Mit Volltextzugriff
(245)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(99)
Humans
(65)
Physics
(59)
Physical Sciences
(47)
Life Sciences & Biomedicine
(41)
Male
(40)
Female
(37)
Technology
(34)
Exact Sciences And Technology
(31)
Materials Science
(30)
Middle Aged
(29)
Physics, Applied
(28)
Aged
(27)
Oncology
(27)
Materials Science, Multidisciplinary
(23)
Sciences Biologiques Et Medicales
(23)
Sciences Medicales
(23)
Adult
(21)
Physics, Condensed Matter
(17)
Optics
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

Variations in PD1, PD-L1, IDO1 and VEGR2 genes and association with outcomes in advanced head and neck squamous cell carcinoma (HNSCC) patients treated with anti-PD1/PD-L1 based immunotherapy

SP-052: The role of PD-L1/PD1 pathway in SCCHN

Next-generation sequencing reveals high intra-individual molecular concordance between primary head and neck tumors and matched local or distant recurrences

PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors

Cetuximab in patients with unresectable cutaneous squamous cell carcinoma is safe and effective: A real-life analysis

Acceptance of the 2009 A(H1N1) influenza vaccine among hospital workers in two French cancer centers

The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit

2800 Cabazitaxel in patients with refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Final results of phase II trial UNICANCER ORL03

PO-164: PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic salivary gland carcinoma

Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximab

EP-1084: Elderly patients concomitant radiotherapy + cetuximab in locally advanced head and neck cancer

PO-075: Induction chemotherapy in locally advanced hypopharynx cancer: treatment outcomes and role of nutritional status

RESULTS FROM THE SAFETY RUN‐IN PERIOD OF THE SYMPATICO STUDY EVALUATING IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

Role of radiotherapy in the management of non-Hodgkin lymphomas

Efficacy of Cetuximab for Unresectable or Advanced Cutaneous Squamous Cell Carcinoma — A Report of Eight Cases

Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer

Reirradiation of head and neck cancers

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older

Head and neck free-flap reconstruction in the elderly

A comparison between distal and proximal port device insertion in head and neck cancer

Suchergebnisse filtern